Covid-19 Impact on Global Pertussis Vaccine Market Size, Status and Forecast 2020-2026

Covid-19 Impact on Global Pertussis Vaccine Market Size, Status and Forecast 2020-2026

Table of Contents
1 Study Coverage
1.1 Pertussis Vaccine Product Introduction
1.2 Market Segments
1.3 Key Pertussis Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pertussis Vaccine Market Size Growth Rate by Type
1.4.2 Whole-cell vaccines
1.4.3 Acellular vaccines
1.5 Market by Application
1.5.1 Global Pertussis Vaccine Market Size Growth Rate by Application
1.5.2 Children
1.5.3 Adults
1.6 Coronavirus Disease 2019 (Covid-19): Pertussis Vaccine Industry Impact
1.6.1 How the Covid-19 is Affecting the Pertussis Vaccine Industry
1.6.1.1 Pertussis Vaccine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Pertussis Vaccine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Pertussis Vaccine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Pertussis Vaccine Market Size Estimates and Forecasts
2.1.1 Global Pertussis Vaccine Revenue 2015-2026
2.1.2 Global Pertussis Vaccine Sales 2015-2026
2.2 Pertussis Vaccine Market Size by Region: 2020 Versus 2026
2.2.1 Global Pertussis Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Pertussis Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Pertussis Vaccine Competitor Landscape by Players
3.1 Pertussis Vaccine Sales by Manufacturers
3.1.1 Pertussis Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Pertussis Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Pertussis Vaccine Revenue by Manufacturers
3.2.1 Pertussis Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Pertussis Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pertussis Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pertussis Vaccine Revenue in 2019
3.2.5 Global Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Pertussis Vaccine Price by Manufacturers
3.4 Pertussis Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Pertussis Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pertussis Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Pertussis Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Pertussis Vaccine Market Size by Type (2015-2020)
4.1.1 Global Pertussis Vaccine Sales by Type (2015-2020)
4.1.2 Global Pertussis Vaccine Revenue by Type (2015-2020)
4.1.3 Pertussis Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pertussis Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Pertussis Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Pertussis Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Pertussis Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pertussis Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Pertussis Vaccine Market Size by Application (2015-2020)
5.1.1 Global Pertussis Vaccine Sales by Application (2015-2020)
5.1.2 Global Pertussis Vaccine Revenue by Application (2015-2020)
5.1.3 Pertussis Vaccine Price by Application (2015-2020)
5.2 Pertussis Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Pertussis Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Pertussis Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Pertussis Vaccine Price Forecast by Application (2021-2026)
6 North America
6.1 North America Pertussis Vaccine by Country
6.1.1 North America Pertussis Vaccine Sales by Country
6.1.2 North America Pertussis Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Pertussis Vaccine Market Facts & Figures by Type
6.3 North America Pertussis Vaccine Market Facts & Figures by Application
7 Europe
7.1 Europe Pertussis Vaccine by Country
7.1.1 Europe Pertussis Vaccine Sales by Country
7.1.2 Europe Pertussis Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pertussis Vaccine Market Facts & Figures by Type
7.3 Europe Pertussis Vaccine Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Pertussis Vaccine by Region
8.1.1 Asia Pacific Pertussis Vaccine Sales by Region
8.1.2 Asia Pacific Pertussis Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Pertussis Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Pertussis Vaccine Market Facts & Figures by Application
9 Latin America
9.1 Latin America Pertussis Vaccine by Country
9.1.1 Latin America Pertussis Vaccine Sales by Country
9.1.2 Latin America Pertussis Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Pertussis Vaccine Market Facts & Figures by Type
9.3 Central & South America Pertussis Vaccine Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Pertussis Vaccine by Country
10.1.1 Middle East and Africa Pertussis Vaccine Sales by Country
10.1.2 Middle East and Africa Pertussis Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Pertussis Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Pertussis Vaccine Market Facts & Figures by Application
11 Company Profiles
11.1 Sanofi Pasteur
11.1.1 Sanofi Pasteur Corporation Information
11.1.2 Sanofi Pasteur Description, Business Overview and Total Revenue
11.1.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Pasteur Pertussis Vaccine Products Offered
11.1.5 Sanofi Pasteur Recent Development
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Description, Business Overview and Total Revenue
11.2.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GSK Pertussis Vaccine Products Offered
11.2.5 GSK Recent Development
11.3 Mitsubishi Tanabe Pharma
11.3.1 Mitsubishi Tanabe Pharma Corporation Information
11.3.2 Mitsubishi Tanabe Pharma Description, Business Overview and Total Revenue
11.3.3 Mitsubishi Tanabe Pharma Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Products Offered
11.3.5 Mitsubishi Tanabe Pharma Recent Development
11.4 Astellas Pharma
11.4.1 Astellas Pharma Corporation Information
11.4.2 Astellas Pharma Description, Business Overview and Total Revenue
11.4.3 Astellas Pharma Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Astellas Pharma Pertussis Vaccine Products Offered
11.4.5 Astellas Pharma Recent Development
11.5 Minhai Biotechnology
11.5.1 Minhai Biotechnology Corporation Information
11.5.2 Minhai Biotechnology Description, Business Overview and Total Revenue
11.5.3 Minhai Biotechnology Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Minhai Biotechnology Pertussis Vaccine Products Offered
11.5.5 Minhai Biotechnology Recent Development
11.6 Wuhan Institute of Biological Products
11.6.1 Wuhan Institute of Biological Products Corporation Information
11.6.2 Wuhan Institute of Biological Products Description, Business Overview and Total Revenue
11.6.3 Wuhan Institute of Biological Products Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Wuhan Institute of Biological Products Pertussis Vaccine Products Offered
11.6.5 Wuhan Institute of Biological Products Recent Development
11.7 Changchun Changsheng Life Sciences
11.7.1 Changchun Changsheng Life Sciences Corporation Information
11.7.2 Changchun Changsheng Life Sciences Description, Business Overview and Total Revenue
11.7.3 Changchun Changsheng Life Sciences Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Changchun Changsheng Life Sciences Pertussis Vaccine Products Offered
11.7.5 Changchun Changsheng Life Sciences Recent Development
11.1 Sanofi Pasteur
11.1.1 Sanofi Pasteur Corporation Information
11.1.2 Sanofi Pasteur Description, Business Overview and Total Revenue
11.1.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Pasteur Pertussis Vaccine Products Offered
11.1.5 Sanofi Pasteur Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Pertussis Vaccine Market Estimates and Projections by Region
12.1.1 Global Pertussis Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Pertussis Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Pertussis Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Pertussis Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Pertussis Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Pertussis Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Pertussis Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Pertussis Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Pertussis Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Pertussis Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Pertussis Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Pertussis Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Pertussis Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Pertussis Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Pertussis Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Pertussis Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Pertussis Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Pertussis Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Pertussis Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Pertussis Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Pertussis Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Pertussis Vaccine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Pertussis Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pertussis Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Pertussis Vaccine Market Segments
Table 2. Ranking of Global Top Pertussis Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pertussis Vaccine Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of Whole-cell vaccines
Table 5. Major Manufacturers of Acellular vaccines
Table 6. COVID-19 Impact Global Market: (Four Pertussis Vaccine Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Pertussis Vaccine Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Pertussis Vaccine Players to Combat Covid-19 Impact
Table 11. Global Pertussis Vaccine Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 12. Global Pertussis Vaccine Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 13. Global Pertussis Vaccine Sales by Regions 2015-2020 (K Doses)
Table 14. Global Pertussis Vaccine Sales Market Share by Regions (2015-2020)
Table 15. Global Pertussis Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Pertussis Vaccine Sales by Manufacturers (2015-2020) (K Doses)
Table 17. Global Pertussis Vaccine Sales Share by Manufacturers (2015-2020)
Table 18. Global Pertussis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Pertussis Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pertussis Vaccine as of 2019)
Table 20. Pertussis Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Pertussis Vaccine Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Pertussis Vaccine Price (2015-2020) (USD/Doses)
Table 23. Pertussis Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Pertussis Vaccine Product Type
Table 25. Date of International Manufacturers Enter into Pertussis Vaccine Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Pertussis Vaccine Sales by Type (2015-2020) (K Doses)
Table 28. Global Pertussis Vaccine Sales Share by Type (2015-2020)
Table 29. Global Pertussis Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Pertussis Vaccine Revenue Share by Type (2015-2020)
Table 31. Pertussis Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Doses)
Table 32. Global Pertussis Vaccine Sales by Application (2015-2020) (K Doses)
Table 33. Global Pertussis Vaccine Sales Share by Application (2015-2020)
Table 34. North America Pertussis Vaccine Sales by Country (2015-2020) (K Doses)
Table 35. North America Pertussis Vaccine Sales Market Share by Country (2015-2020)
Table 36. North America Pertussis Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Pertussis Vaccine Revenue Market Share by Country (2015-2020)
Table 38. North America Pertussis Vaccine Sales by Type (2015-2020) (K Doses)
Table 39. North America Pertussis Vaccine Sales Market Share by Type (2015-2020)
Table 40. North America Pertussis Vaccine Sales by Application (2015-2020) (K Doses)
Table 41. North America Pertussis Vaccine Sales Market Share by Application (2015-2020)
Table 42. Europe Pertussis Vaccine Sales by Country (2015-2020) (K Doses)
Table 43. Europe Pertussis Vaccine Sales Market Share by Country (2015-2020)
Table 44. Europe Pertussis Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Pertussis Vaccine Revenue Market Share by Country (2015-2020)
Table 46. Europe Pertussis Vaccine Sales by Type (2015-2020) (K Doses)
Table 47. Europe Pertussis Vaccine Sales Market Share by Type (2015-2020)
Table 48. Europe Pertussis Vaccine Sales by Application (2015-2020) (K Doses)
Table 49. Europe Pertussis Vaccine Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Pertussis Vaccine Sales by Region (2015-2020) (K Doses)
Table 51. Asia Pacific Pertussis Vaccine Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Pertussis Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Pertussis Vaccine Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Pertussis Vaccine Sales by Type (2015-2020) (K Doses)
Table 55. Asia Pacific Pertussis Vaccine Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Pertussis Vaccine Sales by Application (2015-2020) (K Doses)
Table 57. Asia Pacific Pertussis Vaccine Sales Market Share by Application (2015-2020)
Table 58. Latin America Pertussis Vaccine Sales by Country (2015-2020) (K Doses)
Table 59. Latin America Pertussis Vaccine Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Pertussis Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Pertussis Vaccine Revenue Market Share by Country (2015-2020)
Table 62. Latin America Pertussis Vaccine Sales by Type (2015-2020) (K Doses)
Table 63. Latin America Pertussis Vaccine Sales Market Share by Type (2015-2020)
Table 64. Latin America Pertussis Vaccine Sales by Application (2015-2020) (K Doses)
Table 65. Latin America Pertussis Vaccine Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Pertussis Vaccine Sales by Country (2015-2020) (K Doses)
Table 67. Middle East and Africa Pertussis Vaccine Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Pertussis Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Pertussis Vaccine Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Pertussis Vaccine Sales by Type (2015-2020) (K Doses)
Table 71. Middle East and Africa Pertussis Vaccine Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Pertussis Vaccine Sales by Application (2015-2020) (K Doses)
Table 73. Middle East and Africa Pertussis Vaccine Sales Market Share by Application (2015-2020)
Table 74. Sanofi Pasteur Corporation Information
Table 75. Sanofi Pasteur Description and Major Businesses
Table 76. Sanofi Pasteur Pertussis Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)
Table 77. Sanofi Pasteur Product
Table 78. Sanofi Pasteur Recent Development
Table 79. GSK Corporation Information
Table 80. GSK Description and Major Businesses
Table 81. GSK Pertussis Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)
Table 82. GSK Product
Table 83. GSK Recent Development
Table 84. Mitsubishi Tanabe Pharma Corporation Information
Table 85. Mitsubishi Tanabe Pharma Description and Major Businesses
Table 86. Mitsubishi Tanabe Pharma Pertussis Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)
Table 87. Mitsubishi Tanabe Pharma Product
Table 88. Mitsubishi Tanabe Pharma Recent Development
Table 89. Astellas Pharma Corporation Information
Table 90. Astellas Pharma Description and Major Businesses
Table 91. Astellas Pharma Pertussis Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)
Table 92. Astellas Pharma Product
Table 93. Astellas Pharma Recent Development
Table 94. Minhai Biotechnology Corporation Information
Table 95. Minhai Biotechnology Description and Major Businesses
Table 96. Minhai Biotechnology Pertussis Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)
Table 97. Minhai Biotechnology Product
Table 98. Minhai Biotechnology Recent Development
Table 99. Wuhan Institute of Biological Products Corporation Information
Table 100. Wuhan Institute of Biological Products Description and Major Businesses
Table 101. Wuhan Institute of Biological Products Pertussis Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)
Table 102. Wuhan Institute of Biological Products Product
Table 103. Wuhan Institute of Biological Products Recent Development
Table 104. Changchun Changsheng Life Sciences Corporation Information
Table 105. Changchun Changsheng Life Sciences Description and Major Businesses
Table 106. Changchun Changsheng Life Sciences Pertussis Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)
Table 107. Changchun Changsheng Life Sciences Product
Table 108. Changchun Changsheng Life Sciences Recent Development
Table 109. Global Pertussis Vaccine Sales Forecast by Regions (2021-2026) (K Doses)
Table 110. Global Pertussis Vaccine Sales Market Share Forecast by Regions (2021-2026)
Table 111. Global Pertussis Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 112. Global Pertussis Vaccine Revenue Market Share Forecast by Regions (2021-2026)
Table 113. North America: Pertussis Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 114. North America: Pertussis Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Europe: Pertussis Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 116. Europe: Pertussis Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Asia Pacific: Pertussis Vaccine Sales Forecast by Region (2021-2026) (K Doses)
Table 118. Asia Pacific: Pertussis Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Latin America: Pertussis Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 120. Latin America: Pertussis Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Middle East and Africa: Pertussis Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 122. Middle East and Africa: Pertussis Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 124. Key Challenges
Table 125. Market Risks
Table 126. Main Points Interviewed from Key Pertussis Vaccine Players
Table 127. Pertussis Vaccine Customers List
Table 128. Pertussis Vaccine Distributors List
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Pertussis Vaccine Product Picture
Figure 2. Global Pertussis Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Whole-cell vaccines Product Picture
Figure 4. Acellular vaccines Product Picture
Figure 5. Global Pertussis Vaccine Sales Market Share by Application in 2020 & 2026
Figure 6. Children
Figure 7. Adults
Figure 8. Pertussis Vaccine Report Years Considered
Figure 9. Global Pertussis Vaccine Market Size 2015-2026 (US$ Million)
Figure 10. Global Pertussis Vaccine Sales 2015-2026 (K Doses)
Figure 11. Global Pertussis Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Pertussis Vaccine Sales Market Share by Region (2015-2020)
Figure 13. Global Pertussis Vaccine Sales Market Share by Region in 2019
Figure 14. Global Pertussis Vaccine Revenue Market Share by Region (2015-2020)
Figure 15. Global Pertussis Vaccine Revenue Market Share by Region in 2019
Figure 16. Global Pertussis Vaccine Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Pertussis Vaccine Revenue in 2019
Figure 18. Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Pertussis Vaccine Sales Market Share by Type (2015-2020)
Figure 20. Global Pertussis Vaccine Sales Market Share by Type in 2019
Figure 21. Global Pertussis Vaccine Revenue Market Share by Type (2015-2020)
Figure 22. Global Pertussis Vaccine Revenue Market Share by Type in 2019
Figure 23. Global Pertussis Vaccine Market Share by Price Range (2015-2020)
Figure 24. Global Pertussis Vaccine Sales Market Share by Application (2015-2020)
Figure 25. Global Pertussis Vaccine Sales Market Share by Application in 2019
Figure 26. Global Pertussis Vaccine Revenue Market Share by Application (2015-2020)
Figure 27. Global Pertussis Vaccine Revenue Market Share by Application in 2019
Figure 28. North America Pertussis Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 29. North America Pertussis Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Pertussis Vaccine Sales Market Share by Country in 2019
Figure 31. North America Pertussis Vaccine Revenue Market Share by Country in 2019
Figure 32. U.S. Pertussis Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 33. U.S. Pertussis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Pertussis Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 35. Canada Pertussis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Pertussis Vaccine Market Share by Type in 2019
Figure 37. North America Pertussis Vaccine Market Share by Application in 2019
Figure 38. Europe Pertussis Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 39. Europe Pertussis Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Pertussis Vaccine Sales Market Share by Country in 2019
Figure 41. Europe Pertussis Vaccine Revenue Market Share by Country in 2019
Figure 42. Germany Pertussis Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 43. Germany Pertussis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Pertussis Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 45. France Pertussis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Pertussis Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 47. U.K. Pertussis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Pertussis Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 49. Italy Pertussis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Pertussis Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 51. Russia Pertussis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Pertussis Vaccine Market Share by Type in 2019
Figure 53. Europe Pertussis Vaccine Market Share by Application in 2019
Figure 54. Asia Pacific Pertussis Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 55. Asia Pacific Pertussis Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Pertussis Vaccine Sales Market Share by Region in 2019
Figure 57. Asia Pacific Pertussis Vaccine Revenue Market Share by Region in 2019
Figure 58. China Pertussis Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 59. China Pertussis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Pertussis Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 61. Japan Pertussis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Pertussis Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 63. South Korea Pertussis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Pertussis Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 65. India Pertussis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Pertussis Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 67. Australia Pertussis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Pertussis Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 69. Taiwan Pertussis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Pertussis Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 71. Indonesia Pertussis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Pertussis Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 73. Thailand Pertussis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Pertussis Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 75. Malaysia Pertussis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Pertussis Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 77. Philippines Pertussis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Pertussis Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 79. Vietnam Pertussis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Pertussis Vaccine Market Share by Type in 2019
Figure 81. Asia Pacific Pertussis Vaccine Market Share by Application in 2019
Figure 82. Latin America Pertussis Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 83. Latin America Pertussis Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Pertussis Vaccine Sales Market Share by Country in 2019
Figure 85. Latin America Pertussis Vaccine Revenue Market Share by Country in 2019
Figure 86. Mexico Pertussis Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 87. Mexico Pertussis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Pertussis Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 89. Brazil Pertussis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Pertussis Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 91. Argentina Pertussis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Pertussis Vaccine Market Share by Type in 2019
Figure 93. Latin America Pertussis Vaccine Market Share by Application in 2019
Figure 94. Middle East and Africa Pertussis Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 95. Middle East and Africa Pertussis Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Pertussis Vaccine Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Pertussis Vaccine Revenue Market Share by Country in 2019
Figure 98. Turkey Pertussis Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 99. Turkey Pertussis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Pertussis Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 101. Saudi Arabia Pertussis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. UAE Pertussis Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 103. UAE Pertussis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Pertussis Vaccine Market Share by Type in 2019
Figure 105. Middle East and Africa Pertussis Vaccine Market Share by Application in 2019
Figure 106. Sanofi Pasteur Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Mitsubishi Tanabe Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Minhai Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Wuhan Institute of Biological Products Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Changchun Changsheng Life Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. North America Pertussis Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 114. North America Pertussis Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe Pertussis Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 116. Europe Pertussis Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific Pertussis Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 118. Asia Pacific Pertussis Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America Pertussis Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 120. Latin America Pertussis Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa Pertussis Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 122. Middle East and Africa Pertussis Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs